相关实验视频
Updated: Jul 2, 2025

13:00
Engineering Antiviral Agents via Surface Plasmon Resonance
Published on: June 14, 2022
2.3K
三维结构稳定性和局部静电潜力在SARS-CoV-2冠状病毒尖端蛋白的点突变中
Svetlana H Hristova1, Alexandar M Zhivkov2
1Department of Medical Physics and Biophysics, Medical Faculty, Medical University-Sofia, Zdrave Street 2, 1431 Sofia, Bulgaria.
International journal of molecular sciences
|February 24, 2024
概括
在SARS-CoV-2尖端蛋白中的点突变.
科学领域:
- 病毒学和分子生物学
- 生物物理学的生物物理.
- 计算生物学 计算生物学
背景情况:
- SARS-CoV-2的传染性与其尖端 (S) 蛋白和宿主细胞上的ACE2受体之间的静电相互作用有关.
- 在S蛋白的受体结合域 (RBD) 中的突变可以改变这种相互作用,可能会影响病毒的传播能力.
研究的目的:
- 调查点突变如何影响SARS-CoV-2 S1子单元的静电潜力和3D稳定性.
- 确定这些静电变化是否影响S蛋白与ACE2受体的结合亲和力.
主要方法:
- 在 RBD-ACE2 接口上选择了 15 种具有不同氨基酸特性的突变.
- 对野生型和突变菌株的S1子单元的3D结构的重建.
- 使用蛋白质静电学程序计算折叠的吉布斯自由能量,同电点和依赖pH的表面静电潜力.
主要成果:
- 证明点突变会改变突变残留物周围的局部静电潜力.
- 这些静电电位的变化可以影响S蛋白与ACE2受体之间的关联强度.
- 该研究确定了静电变化与病毒感染性和传染性的潜在变化之间的相关性.
结论:
- 对S1子单元的静电潜力变化的计算分析可以预测SARS-CoV-2突变的相对感染性和传染性.
- 这种方法提供了一种方法,可以根据它们的S蛋白结构和静电学来预测新的病毒变异的行为.
关键词:
在ACE2受体.S-蛋白质是一种S-蛋白质.这就是SARS-CoV-2病毒.传染性 传染性 传染性冠状病毒变体的变体折叠能量是一种折叠能量.电离点是电离点的电离点.突变点突变点突变点突变点突变蛋白质电静电学 蛋白质电静电学表面电位的电力潜力.更多相关视频
06:39High-throughput Confocal Imaging of Quantum Dot-Conjugated SARS-CoV-2 Spike Trimers to Track Binding and Endocytosis in HEK293T Cells
Published on: April 21, 2022
3.1K
08:40Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting
Published on: March 1, 2019
59.0K
相关概念视频
Protein Folding
118.1K
Overview
118.1K
Protein Organization
6.5K
Proteins are polymers of amino acid residues. They are versatile and responsible for different cellular functions, including DNA replication, molecular transport, catalysis, and structural support. Proteins have a hierarchical structure comprising at least three levels of organization: primary, secondary, and tertiary structure. Some large proteins have a quaternary structure where individual protein subunits are linked together.
The primary structure of a protein is its amino acid sequence....
The primary structure of a protein is its amino acid sequence....
6.5K
Mutations
82.2K
Overview
82.2K
Conserved Binding Sites
4.2K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
4.2K
Viral Mutations
32.3K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.3K
Single Nucleotide Polymorphisms-SNPs
15.1K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.1K